iRhythm Technologies (IRTC) Leads Cardiac Monitoring Market with Zio Device, Freedom Capital Initiates Coverage

Rhythm Technologies, Inc. (NASDAQ:IRTC) ranks among the best medical device stocks to invest in. On October 13, Freedom ...
Seeking Alpha

iRhythm Technologies: Unpacking The FDA Warning Letter

iRhythm Technologies, a digital healthcare company specializing in cardiac telemetry products, received a warning letter from the FDA on May 25 detailing multiple issues with its Zio AT device. The ...
Business Insider

Strong Zio AT Business Growth Propels iRhythm's Q2 Revenue Surge, Analysts Say Warning Letter Manageable

iRhythm Technologies Inc's (NASDAQ:IRTC) revenue of $124.1 million increased 21.6% Y/Y, beating the consensus of $120.34 million. The increase was driven by volume growth of Zio services, partially ...
Seeking Alpha

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

SAN FRANCISCO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and ...
Benzinga.com

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says

FDA clears iRhythm's first 510(k) submission for Zio AT device; second approval expected soon. Zio AT provides mobile cardiac telemetry for up to 14 days, aiding in ECG monitoring. Get more ...
WDAF-TV

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

SAN FRANCISCO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced initial research findings on post-market, real-world performance of Zio ® monitor, its ...
Nasdaq

iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT

iRhythm Technologies, Inc. IRTC has received FDA 510(k) clearance for design changes and enhancements previously made to its Zio AT device. These modifications, submitted via letter to file, ensure ...
WPRI 12

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) system, ...
Hosted on MSN

iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?

iRhythm Technologies IRTC shares soared 21.7% in the last trading session to close at $75.59. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Eagle-Tribune

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

Zio ATdevice, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients FDA 510 ...